Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Aug 2022 for Epizyme, Inc.. Read the official filing
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carl Goldfischer: trading record in brief
This profile gathers the share dealings of Carl Goldfischer in Epizyme, Inc., where the filings describe the role as board member. Over a trading history stretching from 12 January 2016 to 12 August 2022, the count stands at 5 filings.
No open-market sale appears; the market trades are 2 purchases. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.
The latest filing, published on 16 August 2022, reports a transaction in Epizyme, Inc. The last insider purchase was made public on 12 January 2016, 3,932 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Carl Goldfischer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
13,060 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028874:0
8,994 shares0Common Stock, par value $0.0001SEC:0000899243-22-018818:0
8,060 shares0Common Stock, par value $0.0001SEC:0000899243-21-023866:0
545,166 sharesCommon Stock, par value $0.0001 per shareSEC:0001209191-16-090969:0
Canonical exit: 11 Apr 2016 (T+90)
10,389 sharesCommon Stock, par value $0.0001 per shareSEC:0001209191-16-090969:1
Canonical exit: 11 Apr 2016 (T+90)
5 of 5 declarations
